000 03674nam a22005175i 4500
001 978-3-642-29265-1
003 DE-He213
005 20140220083315.0
007 cr nn 008mamaa
008 120706s2012 gw | s |||| 0|eng d
020 _a9783642292651
_9978-3-642-29265-1
024 7 _a10.1007/978-3-642-29265-1
_2doi
050 4 _aK7000-7720.22
050 4 _aK7073-7078
072 7 _aLB
_2bicssc
072 7 _aLAM
_2bicssc
072 7 _aLAW051000
_2bisacsh
072 7 _aLAW016000
_2bisacsh
082 0 4 _a340.9
_223
082 0 4 _a340.2
_223
100 1 _aSouto, Eliana B.
_eeditor.
245 1 0 _aPatenting Nanomedicines
_h[electronic resource] :
_bLegal Aspects, Intellectual Property and Grant Opportunities /
_cedited by Eliana B. Souto.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2012.
300 _aXXIII, 457 p. 30 illus., 12 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
520 _aThe book focusses on the fundamental aspects of Patenting Nanomedicines applied in different “Drug Delivery and Targeting Systems”. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning. This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts – Part I is composed of the first 3 chapters, which focus on the “fundamentals” of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.
650 0 _aLaw.
650 0 _aMedicine.
650 0 _aPhilosophy of law.
650 0 _amedicine
_xPhilosophy.
650 1 4 _aLaw.
650 2 4 _aPrivate International Law, International & Foreign Law, Comparative Law.
650 2 4 _aPhilosophy of Medicine.
650 2 4 _aPhilosophy of Law.
650 2 4 _aBiomedicine general.
650 2 4 _aInternational IT and Media Law, Intellectual Property Law.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642292644
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-29265-1
912 _aZDB-2-SHU
999 _c102999
_d102999